A method of assaying bone collagen breakdown levels in a human subject useful to screen for the presence of bone resorption disorders. Also disclosed is a method for monitoring the progression and/or treatment response of a cancer condition which involves or has the potential to progress to a metastatic condition which involves abnormalities in bone resorption rates.
申请公布号
WO9414072(A1)
申请公布日期
1994.06.23
申请号
WO1993US12321
申请日期
1993.12.17
申请人
METRA BIOSYSTEMS, INC.;KUNG, VIOLA, T.;GOMEZ, BALTAZAR, JR.
